AHCO vs. ANAB
AHCO (AdaptHealth Corp.) and ANAB (AnaptysBio, Inc.) are both stocks. Both are in the Healthcare sector — AHCO in Medical Devices, ANAB in Biotechnology. Over the past 5 years, AHCO returned -17.74%/yr vs 27.51%/yr for ANAB. At a 0.14 correlation, their price movements are largely independent.
Performance
AHCO vs. ANAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AHCO achieves a -2.41% return, which is significantly lower than ANAB's 58.54% return.
AHCO
- 1D
- 0.73%
- 1M
- -25.46%
- YTD
- -2.41%
- 6M
- 4.07%
- 1Y
- 9.71%
- 3Y*
- -2.54%
- 5Y*
- -17.74%
- 10Y*
- —
ANAB
- 1D
- -0.04%
- 1M
- -26.57%
- YTD
- 58.54%
- 6M
- 75.64%
- 1Y
- 226.79%
- 3Y*
- 60.13%
- 5Y*
- 27.51%
- 10Y*
- —
AHCO vs. ANAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AHCO AdaptHealth Corp. | -2.41% | 4.62% | 30.59% | -62.07% | -21.42% | -34.88% | 242.08% | 11.70% | 1.34% |
ANAB AnaptysBio, Inc. | 58.54% | 266.16% | -38.19% | -30.88% | -10.82% | 61.63% | 32.31% | -74.53% | -22.84% |
Correlation
The correlation between AHCO and ANAB is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since May 25, 2018 | 0.14 |
Fundamentals
AHCO:
$1.32B
ANAB:
$1.47B
AHCO:
-$0.60
ANAB:
-$0.91
AHCO:
0.43
ANAB:
6.50
AHCO:
0.87
ANAB:
115.33
AHCO:
$3.08B
ANAB:
$232.39M
AHCO:
$260.17M
ANAB:
$245.59M
AHCO:
$380.93M
ANAB:
$52.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AHCO vs. ANAB — Risk / Return Rank
AHCO
ANAB
AHCO vs. ANAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AdaptHealth Corp. (AHCO) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AHCO | ANAB | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.21 | 3.24 | -3.03 |
Sortino ratioReturn per unit of downside risk | 0.67 | 3.63 | -2.96 |
Omega ratioGain probability vs. loss probability | 1.08 | 1.48 | -0.40 |
Calmar ratioReturn relative to maximum drawdown | 0.35 | 8.11 | -7.76 |
Martin ratioReturn relative to average drawdown | 1.06 | 20.93 | -19.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AHCO | ANAB | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.21 | 3.24 | -3.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.31 | 0.42 | -0.73 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.00 | 0.23 | -0.23 |
Drawdowns
AHCO vs. ANAB - Drawdown Comparison
The maximum AHCO drawdown since its inception was -83.84%, smaller than the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for AHCO and ANAB.
Loading charts...
Drawdown Indicators
| AHCO | ANAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.84% | -92.08% | +8.24% |
Max Drawdown (1Y)Largest decline over 1 year | -27.88% | -28.15% | +0.27% |
Max Drawdown (3Y)Largest decline over 3 years | -56.06% | -69.32% | +13.26% |
Max Drawdown (5Y)Largest decline over 5 years | -78.29% | -69.32% | -8.97% |
Current DrawdownCurrent decline from peak | -75.79% | -40.21% | -35.58% |
Average DrawdownAverage peak-to-trough decline | -43.23% | -64.74% | +21.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.21% | 10.92% | -1.71% |
Volatility
AHCO vs. ANAB - Volatility Comparison
AdaptHealth Corp. (AHCO) has a higher volatility of 12.42% compared to AnaptysBio, Inc. (ANAB) at 11.47%. This indicates that AHCO's price experiences larger fluctuations and is considered to be riskier than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AHCO | ANAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.42% | 11.47% | +0.95% |
Volatility (6M)Calculated over the trailing 6-month period | 33.27% | 46.57% | -13.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.49% | 70.75% | -24.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.22% | 65.34% | -7.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.80% | 75.51% | -20.71% |
Dividends
AHCO vs. ANAB - Dividend Comparison
Neither AHCO nor ANAB has paid dividends to shareholders.
Financials
AHCO vs. ANAB - Financials Comparison
This section allows you to compare key financial metrics between AdaptHealth Corp. and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AHCO and ANAB have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AHCO has higher volatility (12.42%) compared to ANAB (11.47%). In terms of maximum drawdown, AHCO dropped -83.84% vs ANAB's -92.08%.
ANAB currently has the higher Sharpe Ratio (3.24 vs 0.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AHCO and ANAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer